These findings suggest that PUS7 may serve as a valuable biomarker for assessing postoperative prognosis in patients with non-small cell lung cancer and indicate that PUS7 could be considered an independent prognostic indicator (Zhang G. et al., 2023). This evidence concerns the gene PUS7 and non-small cell lung carcinoma.